Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, USA; VA Pittsburgh Healthcare System, Pittsburgh, PA 15213, USA; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.
Semin Cancer Biol. 2021 Jun;71:157-169. doi: 10.1016/j.semcancer.2020.06.010. Epub 2020 Jun 21.
The liver is the most commonly involved organ in metastases from a wide variety of solid tumors. The use of biologically and cellularly complex liver tissue systems have shown that tumor cell behavior and therapeutic responses are modulated within the liver microenvironment and in ways distinct from the behaviors in the primary locations. These microphysiological systems have provided unexpected and powerful insights into the tumor cell biology of metastasis. However, neither the tumor nor the liver exist in an isolated tissue situation, having to function within a complete body and respond to systemic events as well as those in other organs. To examine the influence of one organ on the function of other tissues, microphysiological systems are being linked. Herein, we discuss extending this concept to tumor metastases by integrating complex models of the primary tumor with the liver metastatic environment. In addition, inflammatory organs and the immune system can be incorporated into these multi-organ systems to probe the effects on tumor behavior and cancer treatments.
肝脏是多种实体瘤转移最常累及的器官。使用具有生物和细胞复杂性的肝脏组织系统表明,肿瘤细胞的行为和治疗反应在肝脏微环境中受到调节,其方式与原发部位的行为不同。这些微生理系统为转移的肿瘤细胞生物学提供了意想不到的、强大的见解。然而,肿瘤和肝脏都不是孤立的组织,它们必须在完整的体内发挥功能,并对全身事件以及其他器官的事件做出反应。为了研究一个器官对其他组织功能的影响,正在将微生理系统连接起来。在这里,我们讨论通过将原发性肿瘤的复杂模型与肝脏转移环境相结合,将这一概念扩展到肿瘤转移。此外,还可以将炎症器官和免疫系统纳入这些多器官系统,以研究其对肿瘤行为和癌症治疗的影响。